This is the first report to demonstrate the effects of CYP2B6-G516T and CYP3A4-T878C polymorphisms on plasma efavirenz and nevirapine concentrations in rifampicin-treated HIV/TB co-infected Thai adults. The gene discussed is CYP2B6; the disease is tuberculosis.